Press releases // 23 September 2019
Press releases // 11 July 2019
IntegraGen today announced the company’s sales revenue for the first half of 2019. Revenues amounted to 4,168 K€ compared to 3,624 K€ in the first half of 2018, an increase of 15%.
Press releases // 30 June 2019
The mixed shareholders’ general meeting of IntegraGen was held on Thursday, June 13, 2019 at the Bedford Hotel’s premises at 17 rue de l’Arcade in Paris.
At the end of the Combined General Meeting, (…) »
Press releases // 18 April 2019
IntegraGen has announced the company’s financial results for the year ending December 31, 2018. The annual accounts were approved by the Board of Directors held on April 17, 2019.
Click here to view press release.
Press releases // 05 March 2019
IntegraGen and Advanced Biological Laboratories sign global licensing agreement for the commercialization of miRpredX test
IntegraGen and Advanced Biological Laboratories (ABL) have announced the signing of a non-exclusive global licensing agreement enabling ABL to distribute miRpredX™, IntegraGen’s proprietary IVD CE marked diagnostic test that enables clinicians to identify metastatic colorectal cancer patients who have a higher likelihood of response to anti-EGFR therapy.
Press releases // 09 January 2019
IntegraGen announced today its unaudited annual sales revenue for 2018.Sales revenue of €6.9 million (+11%) Very strong increase (+29%) in sequencing services for the R&D segment Strong reduction in cash consumption. Cash position of €4.0 million as of December 31, 2018 Commercial launch of SIRIUS and MERCURY online genomic data (…) »
Press releases // 12 November 2018
IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers
IntegraGen has announced it is collaborating with Google Cloud for the implementation of IntegraGen’s advanced genomic analysis tools, SIRIUS™ and MERCURY™ into the Google Cloud Platform. This partnership will enable widespread online availability, rapid data transfer and enhanced data security to clinicians and researchers utilizing these analytical tools.(…) »